Literature DB >> 15947059

Cerebral small-vessel disease and decline in information processing speed, executive function and memory.

Niels D Prins1, Ewoud J van Dijk, Tom den Heijer, Sarah E Vermeer, Jellemer Jolles, Peter J Koudstaal, Albert Hofman, Monique M B Breteler.   

Abstract

Cerebral small-vessel disease is common in older people and may contribute to the development of dementia. The objective of the present study was to evaluate the relationship between measures of cerebral small-vessel disease on MRI and the rate of decline in specific cognitive domains in participants from the prospective, population-based Rotterdam Scan Study. Participants were 60-90 years of age and free from dementia at baseline in 1995-1996. White matter lesions (WML), cerebral infarcts and generalized brain atrophy were assessed on the baseline MRI. We performed neuropsychological testing at baseline and repeatedly in 1999-2000 and in 2001-2003. We used random-effects models for repeated measures to examine the association between quantitative MRI measures and rate of decline in measures of global cognitive function, information processing speed, executive function and memory. There were a total of 2266 assessments for the 832 participants in the study, with an average time from the initial to last assessment of 5.2 years. Increasing severity of periventricular WML and generalized brain atrophy and the presence of brain infarcts on MRI were associated with a steeper decline in cognitive function. These structural brain changes were specifically associated with decline in information processing speed and executive function. The associations between MRI measures of cerebral small-vessel disease and cognitive decline did not change after additional adjustment for vascular risk factors or depressed mood. After exclusion of participants with an incident stroke, some of the associations of periventricular WML, brain infarcts and generalized brain atrophy with measures of information processing speed and executive function were no longer significant. This may indicate that stroke plays an intermediate role in the relationship between cerebral small-vessel disease and cognitive decline. Our results suggest that in older people cerebral small-vessel disease may contribute to cognitive decline by affecting information processing speed and executive function.

Entities:  

Mesh:

Year:  2005        PMID: 15947059     DOI: 10.1093/brain/awh553

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  229 in total

1.  Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Sergi Martinez-Ramirez; David H Salat; Aaron Schultz; Ashkan Shoamanesh; Alison M Ayres; Anastasia Vashkevich; Diana Rosas; Kristin Schwab; Alexander Leemans; Geert-Jan Biessels; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; M Edip Gurol; Steven M Greenberg
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

2.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

Review 3.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

4.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

5.  Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus.

Authors:  Ned Sacktor; Richard L Skolasky; Christopher Cox; Ola Selnes; James T Becker; Bruce Cohen; Eileen Martin; Eric N Miller
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

6.  Suspected non-AD pathology in mild cognitive impairment.

Authors:  Laura E M Wisse; Nirali Butala; Sandhitsu R Das; Christos Davatzikos; Bradford C Dickerson; Sanjeev N Vaishnavi; Paul A Yushkevich; David A Wolk
Journal:  Neurobiol Aging       Date:  2015-09-07       Impact factor: 4.673

7.  Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors.

Authors:  Laura W de Jong; Lars E Forsberg; Jean-Sébastien Vidal; Sigurdur Sigurdsson; Alex P Zijdenbos; Melissa Garcia; Gudny Eiriksdottir; Vilmundur Gudnason; Mark A van Buchem; Lenore J Launer
Journal:  Neurobiol Aging       Date:  2013-08-28       Impact factor: 4.673

Review 8.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

9.  Dietary Sodium/Potassium Intake Does Not Affect Cognitive Function or Brain Imaging Indices.

Authors:  Kristen L Nowak; Linda Fried; Anna Jovanovich; Joachim Ix; Kristine Yaffe; Zhiying You; Michel Chonchol
Journal:  Am J Nephrol       Date:  2018-01-24       Impact factor: 3.754

10.  Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.

Authors:  Ana Verdelho; Sofia Madureira; José M Ferro; Anna-Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.